NASDAQ: TNGX
Tango Therapeutics Inc Earnings Dates, Reports, Calls

Tango Therapeutics earnings were -$130.3M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest TNGX earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$37.7M, up 29.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TNGX reported annual earnings of -$130.3M, with 28.1% growth. The next TNGX earnings date is May 6, 2025.

TNGX earnings history

Current Revenue
$42.1M
Current Earnings
-$130.3M
Current Profit Margin
-309.7%

TNGX Return on Equity

Current Company
-55.4%
Current Industry
-2%
Current Market
34.1%
TNGX's Return on Equity (-55.4%)... subscribe to Premium to read more.
High Return on Equity Performance

TNGX undefined

Current Company
-35.8%
Current Industry
-0.4%
TNGX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TNGX announces earnings.

TNGX undefined

Current Company
-46.74%
Current Industry
5.9%
TNGX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TNGX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TNGX-$123.85M-$130.30MN/A-$1.19
NKTX-$97.35M-$108.79MN/A-$1.60
FDMT-$154.16M-$160.87MN/A-$2.98
NKTR-$86.70M-$118.96MN/A-$0.58
PBYI$48.08M$30.28M+34.78%$0.62

TNGX earnings dates

Next earnings date
May 6, 2025

Tango Therapeutics Earnings Reports & History FAQ

What were Tango Therapeutics's earnings last quarter?

On TNGX's earnings call on Invalid Date, Tango Therapeutics (NASDAQ: TNGX) reported Q4 2024 earnings per share (EPS) of -$0.34, up 13.33% year over year. Total TNGX earnings for the quarter were -$37.67 million. In the same quarter last year, Tango Therapeutics's earnings per share (EPS) was -$0.30.

If you're new to stock investing, here's how to buy Tango Therapeutics stock.

When does Tango Therapeutics report earnings?

The next TNGX earnings call is Invalid Date. Add TNGX to your watchlist to be reminded of Tango Therapeutics's next earnings date.

What was TNGX's earnings growth in the past year?

As of Tango Therapeutics's earnings date in Invalid Date, Tango Therapeutics's earnings has grown year over year. TNGX earnings in the past year totalled -$130.30 million.

Is Tango Therapeutics profitable or losing money?

As of the last Tango Therapeutics earnings report, Tango Therapeutics is currently losing money. Tango Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$130.30 million, a 28.07% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.